
Accuray Incorporated ARAY
$ 0.52
-0.36%
Annual report 2025
added 02-17-2026
Country |
|
IPO year |
2007 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
103 M |
Market Cap[1] |
$ 53.4 M |
EBITDA (LTM) |
$ -13.9 M |
P/E (LTM) |
-1.93 |
P/S (LTM) |
0.13 |
EPS (LTM) |
-0.27 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 38.77 | -1.27 % | $ 5.78 K | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Cognyte Software Ltd.
CGNT
|
$ 8.09 | 3.45 % | $ 581 M | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.1 | 2.76 % | $ 153 M | Nasdaq Global Market | ||
|
Electromed
ELMD
|
$ 24.5 | 2.17 % | $ 207 M | NYSE American | ||
|
AdaptHealth Corp.
AHCO
|
$ 9.69 | 3.09 % | $ 1.31 B | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.54 | 0.19 % | $ 122 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
CONMED Corporation
CNMD
|
$ 42.93 | -1.11 % | $ 1.33 B | NYSE,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 29.44 | -1.31 % | $ 1.36 B | Nasdaq Capital Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.26 | 2.84 % | $ 113 M | Nasdaq Global Select Market | ||
|
InMode Ltd.
INMD
|
$ 13.55 | -0.37 % | $ 876 M | Nasdaq Global Select Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 105.35 | 1.02 % | $ 1.33 B | Nasdaq Global Select Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 66.26 | -3.17 % | $ 3.61 B | Nasdaq Global Select Market | ||
|
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Nasdaq Global Select Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.47 | -3.92 % | $ 57.5 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.79 | -1.75 % | $ 43 M | Nasdaq Capital Market | ||
|
Medtronic PLC
MDT
|
$ 96.0 | -0.75 % | $ 123 B | NYSE,SPB | ||
|
Align Technology
ALGN
|
$ 181.73 | -0.5 % | $ 13.6 B | Nasdaq Global Select Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Inari Medical
NARI
|
- | - | $ 4.23 B | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 3.97 | 7.88 % | $ 840 M | NYSE | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Abbott Laboratories
ABT
|
$ 113.65 | 0.04 % | $ 198 B | NYSE,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 72.77 | -1.46 % | $ 108 B | NYSE,SPB | ||
|
Orthofix Medical
OFIX
|
$ 12.98 | -0.42 % | $ 514 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.